Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
- PMID: 30030508
- DOI: 10.1038/s41375-018-0211-0
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources